The site is undergoing maintenance on
Thursday, September 10, 8:00 pm through Friday, September 11, 8:00 pm (EDT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 8:00 pm through Friday, September 11, 8:00 pm (EDT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 8:00 pm through Friday, September 11, 8:00 pm (EDT), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Two-color flow cytometric analysis of Ki-67 expression by proliferating MOLT-4 and noncycling human peripheral blood mononuclear cells. Proliferating cells from the human MOLT-4 (T lymphoblastic leukemia, ATCC CRL-1582) cell line and noncycling peripheral blood mononuclear cells (PBMC) were fixed and permeabilized with 70% ice cold ethanol. The cells were washed twice with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656) and stained with BD Horizon™ BUV395 Mouse Anti-Ki-67 antibody (Cat. No. 564071) according to the BD Biosciences support protocol, Flow Cytometry Staining Protocol for Detection of Ki-67. The cells were then counterstained with BD Via-Probe™ [Cat. No. 555815/555816; contains 7-Amino-Actinomycin D (7-AAD)] to stain DNA. Two-color flow cytometric dot plots showing the correlated expression patterns of 7-AAD staining versus Ki-67 were derived from gated events with the forward and side light-scatter characteristics of intact MOLT-4 cells (Left Panel) or PBMC (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ki-67 expression by proliferating MOLT-4 and noncycling human peripheral blood mononuclear cells. Proliferating cells from the human MOLT-4 (T lymphoblastic leukemia, ATCC CRL-1582) cell line and noncycling peripheral blood mononuclear cells (PBMC) were fixed and permeabilized with 70% ice cold ethanol. The cells were washed twice with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656) and stained with BD Horizon™ BUV395 Mouse Anti-Ki-67 antibody (Cat. No. 564071) according to the BD Biosciences support protocol, Flow Cytometry Staining Protocol for Detection of Ki-67. The cells were then counterstained with BD Via-Probe™ [Cat. No. 555815/555816; contains 7-Amino-Actinomycin D (7-AAD)] to stain DNA. Two-color flow cytometric dot plots showing the correlated expression patterns of 7-AAD staining versus Ki-67 were derived from gated events with the forward and side light-scatter characteristics of intact MOLT-4 cells (Left Panel) or PBMC (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ki-67 expression by proliferating MOLT-4 and noncycling human peripheral blood mononuclear cells. Proliferating cells from the human MOLT-4 (T lymphoblastic leukemia, ATCC CRL-1582) cell line and noncycling peripheral blood mononuclear cells (PBMC) were fixed and permeabilized with 70% ice cold ethanol. The cells were washed twice with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656) and stained with BD Horizon™ BUV395 Mouse Anti-Ki-67 antibody (Cat. No. 564071) according to the BD Biosciences support protocol, Flow Cytometry Staining Protocol for Detection of Ki-67. The cells were then counterstained with BD Via-Probe™ [Cat. No. 555815/555816; contains 7-Amino-Actinomycin D (7-AAD)] to stain DNA. Two-color flow cytometric dot plots showing the correlated expression patterns of 7-AAD staining versus Ki-67 were derived from gated events with the forward and side light-scatter characteristics of intact MOLT-4 cells (Left Panel) or PBMC (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ki-67 expression by proliferating MOLT-4 and noncycling human peripheral blood mononuclear cells. Proliferating cells from the human MOLT-4 (T lymphoblastic leukemia, ATCC CRL-1582) cell line and noncycling peripheral blood mononuclear cells (PBMC) were fixed and permeabilized with 70% ice cold ethanol. The cells were washed twice with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656) and stained with BD Horizon™ BUV395 Mouse Anti-Ki-67 antibody (Cat. No. 564071) according to the BD Biosciences support protocol, Flow Cytometry Staining Protocol for Detection of Ki-67. The cells were then counterstained with BD Via-Probe™ [Cat. No. 555815/555816; contains 7-Amino-Actinomycin D (7-AAD)] to stain DNA. Two-color flow cytometric dot plots showing the correlated expression patterns of 7-AAD staining versus Ki-67 were derived from gated events with the forward and side light-scatter characteristics of intact MOLT-4 cells (Left Panel) or PBMC (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ki-67 expression by proliferating MOLT-4 and noncycling human peripheral blood mononuclear cells. Proliferating cells from the human MOLT-4 (T lymphoblastic leukemia, ATCC CRL-1582) cell line and noncycling peripheral blood mononuclear cells (PBMC) were fixed and permeabilized with 70% ice cold ethanol. The cells were washed twice with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656) and stained with BD Horizon™ BUV395 Mouse Anti-Ki-67 antibody (Cat. No. 564071) according to the BD Biosciences support protocol, Flow Cytometry Staining Protocol for Detection of Ki-67. The cells were then counterstained with BD Via-Probe™ [Cat. No. 555815/555816; contains 7-Amino-Actinomycin D (7-AAD)] to stain DNA. Two-color flow cytometric dot plots showing the correlated expression patterns of 7-AAD staining versus Ki-67 were derived from gated events with the forward and side light-scatter characteristics of intact MOLT-4 cells (Left Panel) or PBMC (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Two-color flow cytometric analysis of Ki-67 expression by proliferating MOLT-4 and noncycling human peripheral blood mononuclear cells. Proliferating cells from the human MOLT-4 (T lymphoblastic leukemia, ATCC CRL-1582) cell line and noncycling peripheral blood mononuclear cells (PBMC) were fixed and permeabilized with 70% ice cold ethanol. The cells were washed twice with BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656) and stained with BD Horizon™ BUV395 Mouse Anti-Ki-67 antibody (Cat. No. 564071) according to the BD Biosciences support protocol, Flow Cytometry Staining Protocol for Detection of Ki-67. The cells were then counterstained with BD Via-Probe™ [Cat. No. 555815/555816; contains 7-Amino-Actinomycin D (7-AAD)] to stain DNA. Two-color flow cytometric dot plots showing the correlated expression patterns of 7-AAD staining versus Ki-67 were derived from gated events with the forward and side light-scatter characteristics of intact MOLT-4 cells (Left Panel) or PBMC (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The B56 monoclonal antibody specifically binds to the Ki-67 antigen that is expressed in the nucleus of cycling cells (G1, S, G2, M cell cycle phases). During the G0 phase, the antigen cannot be detected. During interphase of the cell cycle, it is associated with nucleolar components, and it is on the surface of the chromosomes during M phase. Ki-67 is a large protein having 2 alternatively spliced isoforms, an N-terminal forkhead-associated domain, a C-terminal domain that binds to heterochromatin proteins, and multiple phosphorylation sites, the functions of which are still unclear. Because of the strict association of Ki-67 expression with cell proliferation, anti-Ki-67 antibodies are useful for the identification, quantification, and monitoring of growing cell populations.
The antibody was conjugated to BD Horizon BUV395 which has been exclusively developed by BD Biosciences as an optimal dye for use on a 355 nm laser equipped instrument. With an Ex Max at 348 nm and an Em Max at 395 nm, this dye has virtually no spillover into any other detector. BD Horizon BUV395 can be excited with a 355 nm laser and detected with a 379/28 filter.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.